SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 214 filers reported holding SEATTLE GENETICS INC in Q4 2014. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $283,000 | +5.2% | 5,200 | 0.0% | 0.34% | +10.6% |
Q2 2017 | $269,000 | -20.6% | 5,200 | -3.7% | 0.31% | -15.9% |
Q1 2017 | $339,000 | +18.9% | 5,400 | 0.0% | 0.37% | +22.0% |
Q4 2016 | $285,000 | -1.0% | 5,400 | 0.0% | 0.30% | +11.4% |
Q3 2016 | $288,000 | +32.1% | 5,400 | 0.0% | 0.27% | +33.8% |
Q2 2016 | $218,000 | -11.7% | 5,400 | -1.8% | 0.20% | +5.7% |
Q4 2015 | $247,000 | +16.5% | 5,500 | 0.0% | 0.19% | +13.5% |
Q3 2015 | $212,000 | -20.3% | 5,500 | 0.0% | 0.17% | -6.1% |
Q2 2015 | $266,000 | -21.3% | 5,500 | -39.6% | 0.18% | 0.0% |
Q3 2014 | $338,000 | -2.9% | 9,100 | 0.0% | 0.18% | +4.6% |
Q2 2014 | $348,000 | +52.6% | 9,100 | +82.0% | 0.17% | +43.0% |
Q1 2014 | $228,000 | -50.5% | 5,000 | -56.7% | 0.12% | -51.8% |
Q4 2013 | $461,000 | -0.9% | 11,550 | +9.0% | 0.25% | -4.9% |
Q3 2013 | $465,000 | +39.6% | 10,600 | 0.0% | 0.26% | +40.4% |
Q2 2013 | $333,000 | – | 10,600 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |